Login to Your Account

Trubion Starts New Year With Potential $840M Wyeth Deal

By Jennifer Boggs

Wednesday, January 4, 2006
Trubion Pharmaceuticals Inc. signed its largest deal to date and set a high bar for 2006 by partnering with Wyeth Pharmaceuticals in a potential $840 million agreement to develop Trubion's small modular immunopharmaceutical (SMIP) platform. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription